Propranolol for the Treatment of Kaposi Sarcoma in Adults

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

February 1, 2028

Study Completion Date

August 1, 2028

Conditions
Kaposi Sarcoma
Interventions
DRUG

Propranolol Hydrochloride

"Dosing is as follows:~* Patients who weigh 40 to 59.9 kg:~ * 40 mg BID (target)~ * 20 mg BID (half the target)~* Patients who weigh ≥ 60 kg:~ * 60 mg BID (target)~ * 30 mg BID (half the target)"

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

collaborator

The Foundation for Barnes-Jewish Hospital

OTHER

NCT06445166 - Propranolol for the Treatment of Kaposi Sarcoma in Adults | Biotech Hunter | Biotech Hunter